Examkin

Soru

Zorluk: ZorOrdering Imaging Studies

A 64-year-old man with a 45-pack-year smoking history presents to his primary care physician complaining of a persistent cough, worsening exertional dyspnea, and an unintentional 5-kg (11-lb) weight loss over the past two months. Physical examination reveals decreased breath sounds and dullness to percussion in the right upper lung field. The physician initiates a diagnostic workup for suspected bronchogenic carcinoma.

Arrange the following imaging studies in the most appropriate evidence-based chronological sequence for the initial detection, regional characterization, and distant metastatic staging of this patient's suspected condition.

  1. 1Posteroanterior and lateral chest radiography
  2. 2Computed tomography (CT) of the chest with intravenous contrast
  3. 3Fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT)
  4. 4Magnetic resonance imaging (MRI) of the brain with intravenous contrast

Cevap

The correct sequence is: 1) Chest radiography, 2) CT of the chest with contrast, 3) 18F-FDG PET/CT, and 4) MRI of the brain with contrast.
The standard evidence-based sequence for evaluating suspected non-small cell lung cancer progresses logically from less invasive, broad screening to highly specific, targeted staging. It begins with a chest radiograph to identify the gross abnormality. This is followed by a contrast-enhanced CT of the chest to provide high-resolution anatomic characterization of the mass and mediastinum. Once malignancy is strongly suspected anatomically, a whole-body FDG-PET/CT is performed for physiological staging of regional lymph nodes and extrathoracic distant metastases. Finally, because PET/CT has poor sensitivity for cerebral metastases due to high physiologic brain glucose metabolism, a contrast-enhanced MRI of the brain is required to complete the staging process before initiating definitive therapy.

Adım Adım Çözüm

1
Determine the initial imaging modality for a patient presenting with high-risk respiratory symptoms.
Posteroanterior and lateral chest radiography is selected.
It serves as the first-line screening test to quickly and inexpensively establish the presence of a focal pulmonary abnormality.
2
Select the modality to further characterize the pulmonary lesion identified on initial screening.
Computed tomography (CT) of the chest with intravenous contrast is ordered.
A dedicated diagnostic CT provides the necessary anatomic resolution to evaluate the primary tumor's relationship to surrounding structures and assess mediastinal lymphadenopathy.
3
Choose the appropriate imaging test for whole-body physiological staging of the suspected malignancy.
Fluorodeoxyglucose (18F-FDG) PET/CT is performed.
PET/CT is highly sensitive for detecting regional lymph node metastasis and distant spread in the torso, which dictates whether the disease is surgically resectable.
4
Identify the required supplemental imaging to complete distant metastatic staging for non-small cell lung cancer.
Magnetic resonance imaging (MRI) of the brain with intravenous contrast is added.
Because the brain has a naturally high rate of glucose metabolism, PET/CT cannot reliably detect small cerebral metastases; an MRI is required to rule out central nervous system spread prior to definitive treatment.

Anahtar Kavram

The diagnostic and staging imaging workup for suspected non-small cell lung cancer strictly progresses from initial detection (chest radiography) to anatomic characterization (CT chest), followed by systemic physiologic staging (PET/CT), and concludes with targeted evaluation of high-risk sanctuary sites (MRI brain).
Bu soruyu puanla

Konular

Ordering Imaging Studies

Bu konudan daha fazla soru